Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,427 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Class Actions Relating To Opioid Use Disorder Continue Across Canada

    There are multiple ongoing class actions in Canada against pharmaceutical companies related to Opioid Use Disorder (OUD) and its effects. While these proceedings are all currently in their early stages...
    CanadaLitigation, Mediation & Arbitration
    Smart & Biggar
    Smart & Biggar
  • Article

    Niagara Doctor Found Guilty Of Misconduct, Has Licence Revoked

    It was announced on Thursday that Niagara physician Dr. Allan Jackiewicz, who was once chief of obstetrics and gynecology at Niagara Falls General Hospital, has willingly revoked his medical licence.
    CanadaLitigation, Mediation & Arbitration
    Gluckstein Lawyers
    Gluckstein Lawyers
  • Article

    Plaintiff Can Provide Corroborating Evidence Of Change In Function

    On January 22, 2015 the Ontario Court of Appeal released its reasons in the case of Gyorffy v. Drury.
    CanadaLitigation, Mediation & Arbitration
    Miller Thomson
    Miller Thomson
  • Article

    The Latest On Canadian Expert Reports: Ontario’s Highest Court Rejects Notion That Consultations Between Counsel And Experts Must Stop

    The Ontario Court of Appeal has put to rest any notion that the practice of consultation between counsel and expert witnesses to review draft reports is improper.
    CanadaLitigation, Mediation & Arbitration
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Victory For A Healthcare Company In The First Pharmaceutical Product Liability Class Action Trial In Canada

    On October 19, 2016, the Superior Court of Québec released the first ever decision of a Canadian Court ruling on the merits of a pharmaceutical product liability common issues trial.
    CanadaLitigation, Mediation & Arbitration
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    What To Expect From Your Personal Injury Case During Covid-19

    This pandemic has affected every aspect of our daily lives in profound ways.
    CanadaLitigation, Mediation & Arbitration
    Devry Smith Frank LLP
    Devry Smith Frank LLP
  • Article

    Accessing Records Of Family Members Nets Doctor Four-Month Suspension

    A recent decision of the Ontario Physicians and Surgeons Discipline Tribunal (the "Tribunal") emphasizes that a physician must not access a patient's personal health information...
    CanadaPrivacy
    Rosen Sunshine LLP
    Rosen Sunshine LLP
  • Article

    Alberta's Health Information Act: What Is Changing?

    Bill 46: Health Statutes Amendment Act, 2020 (Bill 46) was recently introduced in the Alberta Legislature.
    CanadaPrivacy
    Field Law
    Field Law
  • Article

    Building Code For Medical Devices Of The 21st Century

    It's all fun and games until someone hacks your pacemaker.
    CanadaPrivacy
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    It's Not Too Late To Say Sorry: BC Labour Relations Board Reinstates (Eventually) Remorseful Nurse Terminated For Privacy Breach

    Privacy issues in employment are gaining more and more attention these days, particularly in the health care sector.
    CanadaPrivacy
    CCPartners
    CCPartners
  • Article

    Navigating Privacy Law: A Practical Guide For Private Sector Regulated Health Professionals In Ontario

    In a digital world with highly sophisticated emerging technologies, the need to protect personal information is an essential mandate for health care professionals. The right to privacy is a human right that seeks.
    CanadaPrivacy
    Gowling WLG
    Gowling WLG
  • Article

    New Mandatory Breach Reporting Under The Alberta Health Information Act

    The HIR will also be amended to include specific details on the contents and method of providing the notice of loss or unauthorized access or disclosure of the individually identifying health information.
    CanadaPrivacy
    Gowling WLG
    Gowling WLG
  • Article

    Health Canada Announces Medical Device Safety Action Plan And Publishes Draft Guidance On Cybersecurity

    This update is intended for medical device manufacturers and those interested in the regulation of medical devices
    CanadaTechnology
    Fasken
    Fasken
  • Article

    The Microsoft And NVIDIA Collaboration

    As modern medicine develops, it increasingly relies on technological advancements. One of the more recent and major examples of this is Microsoft's collaboration with NVIDIA...
    CanadaTechnology
    Goodmans LLP
    Goodmans LLP
  • Article

    Health Canada Proposes Changes For Cosmetic Notifications And Labelling, Including Fragrance Allergens

    The Regulations Amending Certain Regulations Concerning the Disclosure of Cosmetic Ingredients ("the draft Regulations") was published in the Canada Gazette, Part I, on Feb. 11, 2023.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    COVID-19 Update: Ontario Announces Provincewide Lockdown Effective December 26, 2020

    On December 21, 2020, the Government of Ontario announced a temporary provincewide shutdown effective 12:01 a.m. on December 26, 2020 (the "Shutdown").
    CanadaCoronavirus (COVID-19)
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    COVID-19 Update: Toronto's Medical Officer Of Health Eases Additional Measures

    Recently, we wrote about the province-wide changes that came into effect as Ontario entered the Roadmap Exit Step on March 1, 2022. As discussed in our blog, subject to applicable exemptions...
    CanadaCoronavirus (COVID-19)
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Alberta’s Bill 11: Important Changes To Employer Sponsored Benefit Plans

    Effective October 1, 2026, important changes will be implemented through Bill 11, the Health Statutes Amendment Act, 2025 (No. 2), that will have immediate implications for Alberta employers.
    CanadaEmployment and HR
    Cassels
    Cassels
  • Article

    B.C. Adopts Recommendations of Pharmaceutical Task Force

    On May 21, 2008, British Columbia's Health Minister, George Abbott, announced that the provincial government has accepted all of the recommendations from the Pharmaceutical Task Force.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    CDR Splits 50-50 In Listing Recommendations In 2007

    According to the latest data reported on its website, the Common Drug Review (CDR) has continued its historic pattern by recommending against the listing of approximately 50% of the new drugs it reviewed in 2007.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Showing 381–400 of 3427 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics